• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症监护抗菌药物耐药性流行病学(ICARE)监测报告,1996年1月至1997年12月数据总结:来自国家医院感染监测(NNIS)系统的报告。

Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Surveillance Report, data summary from January 1996 through December 1997: A report from the National Nosocomial Infections Surveillance (NNIS) System.

出版信息

Am J Infect Control. 1999 Jun;27(3):279-84. doi: 10.1053/ic.1999.v27.a98878.

DOI:10.1053/ic.1999.v27.a98878
PMID:10358233
Abstract

The Intensive Care Antimicrobial Resistance Epidemiology project has established laboratory-based surveillance for antimicrobial resistance and antimicrobial use at a subset of hospitals participating in the National Nosocomial Infections Surveillance system. These data illustrate that, for most antimicrobial resistant organisms studied, rates of resistance were highest in the intensive care unit areas and lowest in the outpatient areas. For most of the antimicrobial agents, the rate of use was highest in the intensive care unit areas in parallel to the pattern seen for resistance. These comparative data on antimicrobial use and resistance among similar areas (ie, intensive care unit or other inpatient areas) can be used as a benchmark by participating hospitals to focus their efforts at addressing antimicrobial resistance.

摘要

重症监护抗菌药物耐药性流行病学项目已在参与国家医院感染监测系统的部分医院建立了基于实验室的抗菌药物耐药性及抗菌药物使用监测。这些数据表明,对于所研究的大多数抗菌药物耐药菌而言,重症监护病房区域的耐药率最高,门诊区域的耐药率最低。对于大多数抗菌药物,其使用频率在重症监护病房区域也是最高的,与耐药情况呈现的模式一致。这些关于相似区域(即重症监护病房或其他住院区域)抗菌药物使用和耐药性的比较数据,可供参与项目的医院用作基准,以集中精力应对抗菌药物耐药性问题。

相似文献

1
Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Surveillance Report, data summary from January 1996 through December 1997: A report from the National Nosocomial Infections Surveillance (NNIS) System.重症监护抗菌药物耐药性流行病学(ICARE)监测报告,1996年1月至1997年12月数据总结:来自国家医院感染监测(NNIS)系统的报告。
Am J Infect Control. 1999 Jun;27(3):279-84. doi: 10.1053/ic.1999.v27.a98878.
2
Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals.美国医院抗菌药物使用与抗菌药物耐药性监测:ICARE项目第二阶段。重症监护抗菌药物耐药性流行病学(ICARE)项目医院。
Clin Infect Dis. 1999 Aug;29(2):245-52. doi: 10.1086/520193.
3
Benchmarking for prevention: the Centers for Disease Control and Prevention's National Nosocomial Infections Surveillance (NNIS) system experience.预防的基准:疾病控制与预防中心国家医院感染监测(NNIS)系统的经验
Infection. 2003 Dec;31 Suppl 2:44-8.
4
[Is the epidemiological surveillance system of nosocomial infections recommended by the American CDC applicable in a Chilean hospital?].[美国疾病控制与预防中心推荐的医院感染流行病学监测系统适用于智利的医院吗?]
Rev Med Chil. 2001 Dec;129(12):1379-86.
5
Stenotrophomonas maltophilia and antibiotic use in German intensive care units: data from Project SARI (Surveillance of Antimicrobial Use and Antimicrobial Resistance in German Intensive Care Units).嗜麦芽窄食单胞菌与德国重症监护病房的抗生素使用:来自SARI项目(德国重症监护病房抗菌药物使用与抗菌药物耐药性监测)的数据
J Hosp Infect. 2006 Nov;64(3):238-43. doi: 10.1016/j.jhin.2006.07.006. Epub 2006 Sep 18.
6
National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002.1993年至2002年从重症监护病房患者中分离出的铜绿假单胞菌菌株的全国抗菌药物耐药性监测。
Antimicrob Agents Chemother. 2004 Dec;48(12):4606-10. doi: 10.1128/AAC.48.12.4606-4610.2004.
7
Antimicrobial susceptibility pattern comparisons among intensive care unit and general ward Gram-negative isolates from the Meropenem Yearly Susceptibility Test Information Collection Program (USA).来自美罗培南年度药敏试验信息收集项目(美国)的重症监护病房和普通病房革兰氏阴性菌分离株的抗菌药敏模式比较。
Diagn Microbiol Infect Dis. 2006 Sep;56(1):57-62. doi: 10.1016/j.diagmicrobio.2005.12.009. Epub 2006 May 2.
8
Impact of revising the National Nosocomial Infection Surveillance System definition for catheter-related bloodstream infection in ICU: reproducibility of the National Healthcare Safety Network case definition in an Australian cohort of infection control professionals.修订重症监护病房导管相关血流感染的国家医院感染监测系统定义的影响:澳大利亚感染控制专业人员队列中国家医疗安全网络病例定义的可重复性
Am J Infect Control. 2009 Oct;37(8):643-8. doi: 10.1016/j.ajic.2009.02.013. Epub 2009 Jul 8.
9
Antimicrobial resistance in the intensive care unit: impact of new patterns.重症监护病房中的抗菌药物耐药性:新模式的影响
Int J Clin Pract Suppl. 1998 Jun;95:14-22.
10
National Nosocomial Infections Surveillance (NNIS) report, data summary from October 1986-April 1996, issued May 1996. A report from the National Nosocomial Infections Surveillance (NNIS) System.国家医院感染监测(NNIS)报告,1986年10月至1996年4月数据摘要,1996年5月发布。国家医院感染监测(NNIS)系统报告。
Am J Infect Control. 1996 Oct;24(5):380-8.

引用本文的文献

1
Emergence of Highly Multidrug-Resistant Bacteria Isolated from Patients with Infections Admitted to Public Hospitals in Southwest Iran.从伊朗西南部公立医院收治的感染患者中分离出的高度耐多药细菌的出现。
Interdiscip Perspect Infect Dis. 2021 Aug 13;2021:5265379. doi: 10.1155/2021/5265379. eCollection 2021.
2
The nitric oxide donor, (Z)-1-[N-(2-aminoethyl)-N-(2-ammonioethyl)amino]diazen-1-ium-1,2-diolate (DETA-NONOate/D-NO), increases survival by attenuating hyperoxia-compromised innate immunity in bacterial clearance in a mouse model of ventilator-associated pneumonia.一氧化氮供体,(Z)-1-[N-(2-氨乙基)-N-(2-氨乙基)氨基]二氮烯-1-基-1,2-二醇盐(DETA-NONOate/D-NO),通过减轻呼吸机相关性肺炎小鼠模型中高氧损伤的固有免疫来提高存活率,从而增强细菌清除能力。
Biochem Pharmacol. 2020 Jun;176:113817. doi: 10.1016/j.bcp.2020.113817. Epub 2020 Jan 20.
3
Invasive and non-invasive diagnostic approaches for microbiological diagnosis of hospital-acquired pneumonia.用于医院获得性肺炎微生物学诊断的有创和无创诊断方法。
Crit Care. 2019 Feb 18;23(1):51. doi: 10.1186/s13054-019-2348-2.
4
Long-term use of selective decontamination of the digestive tract does not increase antibiotic resistance: a 5-year prospective cohort study.长期使用选择性消化道去污染不会增加抗生素耐药性:一项为期 5 年的前瞻性队列研究。
Intensive Care Med. 2011 Sep;37(9):1458-65. doi: 10.1007/s00134-011-2307-0. Epub 2011 Jul 19.
5
Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency Medicine (Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin (DIVI)).脓毒症的预防、诊断、治疗及随访:德国脓毒症协会(Deutsche Sepsis-Gesellschaft e.V. (DSG))和德国重症监护与急诊医学跨学科协会(Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin (DIVI))S-2k指南第1版修订本
Ger Med Sci. 2010 Jun 28;8:Doc14. doi: 10.3205/000103.
6
[Prevention, diagnosis, treatment, and follow-up care of sepsis. First revision of the S2k Guidelines of the German Sepsis Society (DSG) and the German Interdisciplinary Association for Intensive and Emergency Care Medicine (DIVI)].[脓毒症的预防、诊断、治疗及随访。德国脓毒症协会(DSG)和德国重症与急诊医学跨学科协会(DIVI)S2k指南首次修订版]
Anaesthesist. 2010 Apr;59(4):347-70. doi: 10.1007/s00101-010-1719-5.
7
Characterization of methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci and extended-spectrum beta-lactamase-producing Escherichia coli in intensive care units in Canada: Results of the Canadian National Intensive Care Unit (CAN-ICU) study (2005-2006).加拿大重症监护病房中耐甲氧西林金黄色葡萄球菌、万古霉素耐药肠球菌和产超广谱β-内酰胺酶大肠埃希菌的特征:加拿大国家重症监护病房(CAN-ICU)研究(2005-2006 年)的结果。
Can J Infect Dis Med Microbiol. 2008 May;19(3):243-9. doi: 10.1155/2008/714846.
8
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.加拿大重症监护病房中的耐抗菌性病原体:2005 - 2006年加拿大国家重症监护病房(CAN - ICU)研究结果
Antimicrob Agents Chemother. 2008 Apr;52(4):1430-7. doi: 10.1128/AAC.01538-07. Epub 2008 Feb 19.
9
Enteral vancomycin controls methicillin-resistant Staphylococcus aureus endemicity in an intensive care burn unit: a 9-year prospective study.肠内应用万古霉素控制重症监护烧伤病房耐甲氧西林金黄色葡萄球菌的流行:一项9年前瞻性研究。
Ann Surg. 2007 Mar;245(3):397-407. doi: 10.1097/01.sla.0000250418.14359.31.
10
Antioxidants preserve macrophage phagocytosis of Pseudomonas aeruginosa during hyperoxia.抗氧化剂在高氧环境下可维持巨噬细胞对铜绿假单胞菌的吞噬作用。
Free Radic Biol Med. 2007 May 1;42(9):1338-49. doi: 10.1016/j.freeradbiomed.2007.01.031. Epub 2007 Jan 23.